BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18193438)

  • 1. Peritoneal disseminated recurrence and lung metastasis after surgery for stage IA uterine papillary serous carcinoma of the endometrium: a case report.
    Kanayama S; Yamada Y; Haruta S; Naruse K; Furukawa N; Kawaguchi R; Yoshida S; Sakata M; Sado T; Kitanaka T; Oi H; Kobayashi H
    Arch Gynecol Obstet; 2008 Sep; 278(3):277-80. PubMed ID: 18193438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
    Kiess AP; Damast S; Makker V; Kollmeier MA; Gardner GJ; Aghajanian C; Abu-Rustum NR; Barakat RR; Alektiar KM
    Gynecol Oncol; 2012 Nov; 127(2):321-5. PubMed ID: 22850412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma.
    Thomas MB; Mariani A; Cliby WA; Keeney GA; Podratz KC; Dowdy SC
    Gynecol Oncol; 2007 Nov; 107(2):186-9. PubMed ID: 17688926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).
    Dietrich CS; Modesitt SC; DePriest PD; Ueland FR; Wilder J; Reedy MB; Pavlik EJ; Kryscio R; Cibull M; Giesler J; Manahan K; Huh W; Cohn D; Powell M; Slomovitz B; Higgins RV; Merritt W; Hunter J; Puls L; Gehrig P; van Nagell JR
    Gynecol Oncol; 2005 Dec; 99(3):557-63. PubMed ID: 16154185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
    Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE
    Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC).
    Fields AL; Einstein MH; Novetsky AP; Gebb J; Goldberg GL
    Gynecol Oncol; 2008 Jan; 108(1):201-6. PubMed ID: 17997145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
    Kelly MG; O'Malley D; Hui P; McAlpine J; Dziura J; Rutherford TJ; Azodi M; Chambers SK; Schwartz PE
    Gynecol Oncol; 2004 Dec; 95(3):469-73. PubMed ID: 15581948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma.
    Altaras MM; Bernheim J; Zehavi T; Drucker L; Uziel O; Fishman A
    Gynecol Oncol; 2002 Feb; 84(2):245-51. PubMed ID: 11812082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy in uterine papillary serous carcinoma.
    Resnik E; Taxy JB
    Gynecol Oncol; 1996 Jul; 62(1):123-7. PubMed ID: 8690284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of primary serous papillary carcinoma with unusual clinical presentation: distant lympho nodes metastasis without peritoneal dissemination.
    Yonehara T; Yamaguchi T; Azuma M; Minobe S; Sakuragi N
    Arch Gynecol Obstet; 2008 Dec; 278(6):579-83. PubMed ID: 18338176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission with carboplatin of paclitaxel resistant primary peritoneal papillary serous carcinoma: case report.
    Herrada J; Kudelka AP; Tornos C; Shin DM; Kavanagh JJ; Edwards CL; Verschraegen CF
    Eur J Gynaecol Oncol; 1997; 18(1):39-41. PubMed ID: 9061321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary serous adenocarcinoma of the uterine cervix: a case report.
    Yüksel H; Sezer SD; Küçük M; Riza Obadaşi A; Döger FK
    Eur J Gynaecol Oncol; 2011; 32(2):240-2. PubMed ID: 21614930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal papillary serous carcinoma: response to Taxol in platinum resistant disease.
    Wilailak S; Kudelka AP; Donner LR; Silva E; Mante R; Kavanagh JJ
    Eur J Gynaecol Oncol; 1995; 16(3):187-9. PubMed ID: 7664764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of stage III or IV primary peritoneal serous papillary carcinoma.
    Dubernard G; Morice P; Rey A; Camatte S; Fourchotte V; Thoury A; Pomel C; Pautier P; Lhommé C; Duvillard P; Castaigne D
    Eur J Surg Oncol; 2004 Nov; 30(9):976-81. PubMed ID: 15498644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a preoperative predictive factor for lymph node metastasis in uterine papillary serous carcinoma: long-term results from a single institution.
    Baek MH; Lee SW; Park JY; Kim D; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2015 Jan; 25(1):69-74. PubMed ID: 25470688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.
    Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH
    Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
    Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
    Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Case of Double Cancers of the Stomach and Endometrium with Peritoneal Metastasis].
    Kobayashi R; Takiguchi N; Nabeya Y; Ikeda A; Souda H; Kainuma O; Tonooka T; Imanishi S; Arimitsu H; Chibana T; Ishige F; Sasaki K; Yamamoto H
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2003-5. PubMed ID: 26805245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, non-randomized phase 2 clinical trial of carboplatin plus paclitaxel with sequential radical pelvic radiotherapy for uterine papillary serous carcinoma.
    Obermair A; Mileshkin L; Bolz K; Kondalsamy-Chennakesavan S; Cheuk R; Vasey P; Wyld D; Goh J; Nicklin JL; Perrin LC; Sykes P; Janda M
    Gynecol Oncol; 2011 Feb; 120(2):179-84. PubMed ID: 21126755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.